| A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability M Rodriguez-Peralvarez, TV Luong, L Andreana, T Meyer, AP Dhillon, ... Annals of surgical oncology 20, 325-339, 2013 | 665 | 2013 |
| Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients J Colmenero, M Rodríguez-Perálvarez, M Salcedo, A Arias-Milla, ... Journal of hepatology 74 (1), 148-155, 2021 | 359 | 2021 |
| Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the consensus on … JM Neuberger, WO Bechstein, DRJ Kuypers, P Burra, F Citterio, ... Transplantation 101 (4S), S1-S56, 2017 | 342 | 2017 |
| Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma M Rodríguez-Perálvarez, E Tsochatzis, MC Naveas, G Pieri, ... Journal of hepatology 59 (6), 1193-1199, 2013 | 266 | 2013 |
| Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy SF Atabani, C Smith, C Atkinson, RW Aldridge, M Rodriguez-Perálvarez, ... American Journal of Transplantation 12 (9), 2457-2464, 2012 | 219 | 2012 |
| Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis M Rodríguez-Perálvarez, G Germani, T Darius, J Lerut, E Tsochatzis, ... American Journal of Transplantation 12 (10), 2797-2814, 2012 | 197 | 2012 |
| Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic … C Crossan, EA Tsochatzis, L Longworth, K Gurusamy, B Davidson, ... | 191 | 2015 |
| Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome M Rodríguez-Perálvarez, G Germani, V Papastergiou, E Tsochatzis, ... Journal of hepatology 58 (2), 262-270, 2013 | 133 | 2013 |
| Activation of mTOR signaling pathway in hepatocellular carcinoma G Ferrín, M Guerrero, V Amado, M Rodríguez-Perálvarez, M De la Mata International Journal of Molecular Sciences 21 (4), 1266, 2020 | 121 | 2020 |
| Liver transplantation: immunosuppression and oncology M Rodríguez-Perálvarez, M De la Mata, AK Burroughs Current opinion in organ transplantation 19 (3), 253-260, 2014 | 121 | 2014 |
| Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline R Aller, C Fernandez-Rodriguez, O Lo Iacono, R Banares, J Abad, ... Gastroenterología y Hepatología (English Edition) 41 (5), 328-349, 2018 | 118 | 2018 |
| Biopsy‐proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal M Rodríguez‐Perálvarez, JM Rico‐Juri, E Tsochatzis, P Burra, ... Transplant International 29 (9), 961-973, 2016 | 93 | 2016 |
| Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: modern surgical resection as a feasible alternative to transarterial chemoemolization R Ciria, P López-Cillero, AB Gallardo, J Cabrera, M Pleguezuelo, ... European Journal of Surgical Oncology (EJSO) 41 (9), 1153-1161, 2015 | 80 | 2015 |
| Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation AJ Montano-Loza, ML Rodríguez-Perálvarez, GP Pageaux, ... Journal of Hepatology 78 (6), 1199-1215, 2023 | 78 | 2023 |
| Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH M Reig, A Forner, MA Ávila, C Ayuso, B Mínguez, M Varela, I Bilbao, ... Medicina Clínica (English Edition) 156 (9), 463. e1-463. e30, 2021 | 74 | 2021 |
| Maintenance immunosuppression for adults undergoing liver transplantation: a network meta‐analysis M Rodríguez‐Perálvarez, M Guerrero‐Misas, D Thorburn, BR Davidson, ... Cochrane Database of Systematic Reviews, 2017 | 74 | 2017 |
| Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma JL López-Cánovas, M del Rio-Moreno, H García-Fernandez, ... Cancer Letters 496, 72-83, 2021 | 73 | 2021 |
| Transarterial embolization as neo‐adjuvant therapy pretransplantation in patients with hepatocellular carcinoma E Tsochatzis, M Garcovich, L Marelli, V Papastergiou, E Fatourou, ... Liver International 33 (6), 944-949, 2013 | 73 | 2013 |
| Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation M Rodríguez‐Perálvarez, J Colmenero, A González, M Gastaca, A Curell, ... American Journal of Transplantation 22 (6), 1671-1682, 2022 | 70 | 2022 |
| Dysregulation of the splicing machinery is associated to the development of nonalcoholic fatty liver disease M del Río-Moreno, E Alors-Pérez, S González-Rubio, G Ferrín, O Reyes, ... The Journal of Clinical Endocrinology & Metabolism 104 (8), 3389-3402, 2019 | 68 | 2019 |
